Arvind, A., Kanzaki, H., Ahmed, F., Fujiwara, N., Hoshida, Y., & Singal, A. G. (2025). Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma. Wiley. https://doi.org/10.1111/apt.70355
Chicago-Zitierstil (17. Ausg.)Arvind, Ashwini, Hiroaki Kanzaki, Fouzia Ahmed, Naoto Fujiwara, Yujin Hoshida, und Amit G. Singal. Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma. Wiley, 2025. https://doi.org/10.1111/apt.70355.
MLA-Zitierstil (9. Ausg.)Arvind, Ashwini, et al. Research Communication: Serum Metabolomic Signatures Predict Tumour Recurrence After Resection or Ablation in Patients With Early‐Stage Hepatocellular Carcinoma. Wiley, 2025. https://doi.org/10.1111/apt.70355.